The Genomic Applications Partnership Program (GAPP) funds translational research and development projects that address real-world challenges and opportunities as identified by industry, government, not-for-profits, and other “receptors” of genomics knowledge and technology. Launched on June 03, 2013, Genome Canada’s GAPP program aims to fund projects that have a clear and defined partnership between Academia and User partners (receptors) to promote the application of genomics-derived solutions that address key sector challenges or opportunities and which will have socioeconomic benefit to Canada.
Funded Ontario GAPP Projects
On March 9, 2022, The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced federal support through Genome Canada to five Ontario Genomics-led and co-led research and development projects as part of the Genomic Applications Partnership Program (GAPP), that will mobilize genomics out of the lab and deliver real-world benefits.
- YCharOS – Antibody Characterization Through Open Science – From Viruses to Human Proteins
- Fast Track Diagnosis of Stress, Disease, Phenology and Growth (FastPheno)
- Cardiovascular Biomarker Translation Team 2 – Atrial Fibrillation
- Development of an Epigenomic Profiling Tool to Facilitate Precision Medicine in Early Breast Cancer